News25/Ratings7
News · 26 weeks67+8%
2025-10-262026-04-19
Mix3190d
- Insider19(61%)
- SEC Filings5(16%)
- Other3(10%)
- Leadership2(6%)
- Earnings2(6%)
Latest news
25 items- INSIDERSEC Form 4 filed by Chief Administrative Officer England Kristin4 - Oncology Institute, Inc. (0001799191) (Issuer)
- INSIDERSEC Form 4 filed by Chief Clinical Officer Langsam Jeffrey4 - Oncology Institute, Inc. (0001799191) (Issuer)
- INSIDERSEC Form 4 filed by Kaushal Mohit4 - Oncology Institute, Inc. (0001799191) (Issuer)
- SECSEC Form 144 filed by The Oncology Institute Inc.144 - Oncology Institute, Inc. (0001799191) (Subject)
- INSIDERSEC Form 4 filed by Chernett Jorey4 - Oncology Institute, Inc. (0001799191) (Issuer)
- PRThe Oncology Institute Achieves $1.8 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 3, Marking Significant Period-Over-Period ImprovementCERRITOS, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ:TOI), a leading value-based oncology practice, achieved $1.8 million in Medicare savings during Performance Period 3 of the Centers for Medicare & Medicaid Services' Enhancing Oncology Model (EOM) through its California professional corporation, with savings equating to more than $6,400 per patient episode. This represents a significant increase from Performance Period 2, when TOI generated $1.1 million in savings, or more than $3,500 per episode. For the second consecutive performance period, TOI earned the maximum score on avoidable emergency department visits and hospital admissio
- PRThe Oncology Institute to Participate in the 25th Annual Needham Healthcare ConferenceCERRITOS, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the 25th Annual Needham Healthcare Conference, being held virtually on Wednesday, April 15, 2026, including a fireside chat at 3:45 p.m. ET. A webcast link of the presentation will be accessible through the Investor Relations section of the Company's website at https://investors.theoncologyinstitute.com/. About The Oncology Institute (www.theoncologyinstitute.com): Founded in 2007, The Oncology Insti
- PRThe Oncology Institute Names Minh Merchant Chief Legal OfficerCERRITOS, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced that Minh Merchant has joined the organization as Chief Legal Officer. In this role, Ms. Merchant will oversee legal, regulatory, compliance and privacy functions as TOI continues to scale. This role will be essential in enabling the company to continue its growth trajectory while further enhancing its mission to be a trusted healthcare partner to oncology patients and payors. Ms. Merchant has more than two decades of experience advising public and private healthcare organizations, including significant
- INSIDERSEC Form 4 filed by Langsam Jeffrey4 - Oncology Institute, Inc. (0001799191) (Issuer)
- INSIDERSEC Form 4 filed by England Kristin4 - Oncology Institute, Inc. (0001799191) (Issuer)
- INSIDERSEC Form 4 filed by Podnos Yale4 - Oncology Institute, Inc. (0001799191) (Issuer)
- INSIDERSEC Form 4 filed by Carter Robert Ross4 - Oncology Institute, Inc. (0001799191) (Issuer)
- INSIDERSEC Form 4 filed by Virnich Daniel4 - Oncology Institute, Inc. (0001799191) (Issuer)
- INSIDERSEC Form 4 filed by Chernett Jorey4 - Oncology Institute, Inc. (0001799191) (Issuer)
- INSIDERSEC Form 4 filed by Chernett Jorey4 - Oncology Institute, Inc. (0001799191) (Issuer)
- INSIDERSEC Form 4 filed by Chernett Jorey4 - Oncology Institute, Inc. (0001799191) (Issuer)
- INSIDERSEC Form 4 filed by Chernett Jorey4 - Oncology Institute, Inc. (0001799191) (Issuer)
- INSIDERSEC Form 3 filed by new insider Tzoumakas Kimberly Jo3 - Oncology Institute, Inc. (0001799191) (Issuer)
- INSIDERSEC Form 4 filed by The Oncology Institute Inc.4 - Oncology Institute, Inc. (0001799191) (Issuer)
- INSIDERSEC Form 4 filed by The Oncology Institute Inc.4 - Oncology Institute, Inc. (0001799191) (Issuer)
- INSIDERSEC Form 4 filed by The Oncology Institute Inc.4 - Oncology Institute, Inc. (0001799191) (Issuer)
- INSIDERLarge owner Chernett Jorey bought $1,225,101 worth of shares (398,985 units at $3.07), increasing direct ownership by 4% to 10,251,929 units (SEC Form 4)4 - Oncology Institute, Inc. (0001799191) (Issuer)
- INSIDERNew insider Chernett Jorey claimed ownership of 9,852,944 shares (SEC Form 3)3 - Oncology Institute, Inc. (0001799191) (Issuer)
- SECThe Oncology Institute Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Oncology Institute, Inc. (0001799191) (Filer)
- SECSEC Form 10-K filed by The Oncology Institute Inc.10-K - Oncology Institute, Inc. (0001799191) (Filer)